Medtronic Goes Small With Leadless Pacer, Cardiac Monitor
This article was originally published in The Gray Sheet
The firm announced the first U.S. implant for its investigational Micra transcatheter, leadless pacing system, and the global launch of its miniature Reveal LINQ implantable cardiac monitor.
You may also be interested in...
The firm’s ultra-small leadless pacing system has been cleared to launch in Europe, where it will face off with St. Jude’s Nanostim, which is slowly recovering from a pause in implants in 2014.
Congestive heart failure is among the leading indications with regulatory catalysts expected in the next two years, driven by ventricular assist devices. Data from Informa's MedDeviceTracker.
Medtronic will exercise its option to acquire Corventis to bring its non-invasive cardiac telemetry technologies to the U.S. and Europe by later this year.